Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

SB1317 (TG-02)

A potent inhibitor of CDK2, JAK2, and FLT3
Catalog #: B3218
SKU-Size Size Price Qty
B3218-5 5 mg
B3218-25 25 mg
More Sizes Get Quote

Product Details

Alternate Name (16E)-14-methyl-20-oxa-5,7,14,27-tetrazatetracyclo[,6.18,12]heptacosa-1(25),2(27),3,5,8,10,12(26),16,21,23-decaene; Zotiraciclib
Peptide Sequence N/A
Appearance Crystalline solid
CAS # 1204918-72-8
Molecular Formula C₂₃H₂₄N₄O
Molecular Weight 372.46
Purity ≥98%
Solubility >20 mg/ml DMSO
InChi InChI=1S/C23H24N4O/c1-27-13-3-2-4-14-28-21-10-6-8-19(16-21)22-11-12-24-23(26-22)25-20-9-5-7-18(15-20)17-27/h2-3,5-12,15-16H,4,13-14,17H2,1H3,(H,24,25,26)/b3-2+
PubChem CID 16739650
Handling Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
Storage Conditions -20ºC
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.


SB1317 is a potent inhibitor of CDK2, JAK2, and FLT3 with IC50 of 13, 73, and 56 nM, respectively. SB1317 may be useful for the treatment of cancer that crosses the blood brain barrier and acts by depleting Myc through the inhibition of cyclin-dependent kinase 9 (CDK9).

Why buy BioVision Products?
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.